سعر اسروبلاد 100مجم جل 30 كيس 2022

Oxybutynin 100 mg topical gel in single-dose sachets, 30 sachets (Al Esraa Pharmaceutical Optima).

• Treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.Population: AdultsDailyMed (U.S. National Library of Medicine)

• Most common (incidence over 5% and above placebo): dry mouth and application-site reactions.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Urinary retention; gastric retention; uncontrolled narrow-angle glaucoma; known hypersensitivity to the gel, including skin hypersensitivity.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Use caution in clinically significant bladder outflow obstruction (urinary retention), gastrointestinal obstructive disorders or decreased motility, gastroesophageal reflux, and myasthenia gravis; discontinue if skin hypersensitivity occurs; risk of transference to others through skin contact.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• No adequate and well-controlled studies of topical or oral oxybutynin in pregnant women; animal studies showed no fetal harm. Should not be given to pregnant women unless the probable clinical benefits outweigh the possible hazards.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• It is not known whether oxybutynin is excreted in human milk; use caution in nursing women.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

English text not available for this section.